 |
인쇄하기
취소
|
Dong-A overtakes Sanofi-Aventis Korea
Dong-A Pharm retook the number one spot in the local prescription drug market, industry data showed recently.
According to IMS data, Dong-A’s second-quarter ethical sales came in at 107.7 billion won, beating that of Sanofi-Aventis Korea by 9.9 billion won. Dong-A’s sales during the first quarter of the year were recorded at 102.4 billion won, up 27.4 percent compared with 97.0 billion won f...
According to IMS data, Dong-A’s second-quarter ethical sales came in at 107.7 billion won, beating that of Sanofi-Aventis Korea by 9.9 billion won. Dong-A’s sales during the first quarter of the year were recorded at 102.4 billion won, up 27.4 percent compared with 97.0 billion won f...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.